Dipylon Medical (Clinical Microdialysis Solutions Business) is Biotechnology in Sweden that focus on monitoring therapy business. They cover business area such as provider, clinical microdialysis service, drug developer, researcher, caregiver, clinical research, monitoring therapy.
-
Monitoring Therapy
-
Dalvägen 10
169 56 Solna
Sweden
Private
providerclinical microdialysis servicedrug developerresearchercaregiverclinical researchmonitoring therapy
* We use standard office opening hours in near Dipylon Medical (Clinical Microdialysis Solutions Business)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Dipylon Medical (Clinical Microdialysis Solutions Business) is Biotechnology business from Sweden that founded in - ( years old in ), Dipylon Medical (Clinical Microdialysis Solutions Business) business is focusing on Monitoring Therapy.
Dipylon Medical (Clinical Microdialysis Solutions Business) headquarter office and corporate office address is located in Dalvägen 10 169 56 Solna Sweden.
Dipylon Medical (Clinical Microdialysis Solutions Business) was founded in Sweden.
In , Dipylon Medical (Clinical Microdialysis Solutions Business) is currently focus on monitoring therapy sector.
Above is snippet of Google Trends for "monitoring therapy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Dipylon Medical (Clinical Microdialysis Solutions Business), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.